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ess: huang.tony@epa.gSummary The single exhalation analysis of carbon monoxide, acetylene, and
methane allows the determination of intrabreath (regional) DL, pulmonary capillary
blood flow and ventilation inhomogeneities during rest and exercise. We reasoned
that this technique might be more sensitive in detecting regional pulmonary
capillary abnormalities than resting single breath DL (DLsb). We selected a group of
breast cancer patients in high-dose chemotherapy (HDCT) protocols who were at risk
for pulmonary injury. We grouped the patients into pre-HDCT and post-HDCT, and
used resting DLsb to further categorize the latter into those with and without
pulmonary injury. We found that exercise DL increases were blunted in post-HDCT
patients with low resting DLsb. More importantly, even in post-HDCT patients with
normal resting DLsb, exercise DL response was reduced in the slowest emptying lung
units along with evidence for ventilation inhomogeneities (increased methane
slope). We conclude that exercise assessments of DL at low lung volumes and gas
mixing properties may be sensitive indicators of lung injury.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Carbon monoxide (CO) uptake from the lung is
largely determined by alveolar capillary membraneElsevier Ltd. All rights reserve
y Facilities, EPA, CB 7315,
, NC 27599, USA. Tel.:
ov (Y.-C.T. Huang).diffusivity and the volume of blood in the pulmon-
ary capillaries.1–4 Traditional measurements of the
lung CO uptake (diffusing capacity of the lung [DL]
or transfer factor) have usually focused on upright
subjects at rest. Morphological analyses, however,
have shown that under these conditions pulmonary
capillaries are not fully recruited—especially in the
apex—nor fully dilated in much of the remainder of
the lung.4–9 With exercise and increased blood flowd.
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Regional DLCO and lung injury 1227through the lungs, many of these pulmonary
capillaries, however, can be recruited and/or
dilated, which in large part explains the increase
in DL during exercise reported by many investiga-
tors.2,10,11
From these concepts, we might speculate that
functional abnormalities in pulmonary capillaries
that do not appreciably affect resting DL might be
better detected by an abnormal DL response to
exercise. Exercise DL responses have been shown to
be blunted in patients with several diffuse lung
diseases and low resting single breath DL (DLsb),
including idiopathic pulmonary fibrosis and sarcoi-
dosis.12,13 The DL response to exercise, however,
has not been systematically evaluated in patients
at risk for lung injury but with normal resting DLsb
values. Part of the reason for this is that the
standard 10 s breath-hold single breath DL techni-
que is difficult to perform with exercise.
We have previously reported a single exhalation
DL (DLexh) technique using real-time gas analysis
that does not require a breath-hold maneuver and
is thus easier to perform under exercise condi-
tions.10,11,14,15 This technique also allows analysis
of acetylene (C2H2) uptake to assess pulmonary
capillary blood flow (Q c) and the inert gas methane
(CH4) to assess evenness of ventilation. Moreover,
because the DLexh technique uses real-time gas
analysis, CO uptake can be further analyzed over
discrete volumes of exhaled gas thereby permitting
assessment of DL in early versus late emptying lung
regions (DL intrabreath analysis—DLib).
10,11,14,15
We reasoned that subtle regional DL (pulmonary
capillary) abnormalities that would be undetected
with an overall DLsb or DLexh measurement at rest
might become evident with the DLib approach,
especially under exercise conditions. Accordingly,
we recruited a group of breast cancer patients in
autologous bone marrow transplantation and cyto-
toxic high-dose chemotherapy (HDCT) protocols
who were at risk for pulmonary vascular injury.
These patients performed the single exhalation
technique with DLib analysis at rest and during
exercise to test the hypothesis that exercise DL,
especially in slower emptying regions of the lung,
would be a sensitive indicator of subtle pulmonary
capillary abnormalities in these high-risk patients.Methods
Study population
Patients with Stage III and IV breast cancer enrolled
in HDCT/autologous bone marrow transplantationprotocols at Duke University Cancer Center were
recruited. All patients were assessed at the time of
a routine clinic visit that included a high-resolution
chest computerized tomography (CT) and pulmon-
ary function testing (spirometry, lung volume
determination and DLsb). Patients were grouped
according to whether they had not yet received
HDCT (pre-HDCT group) or they had received HDCT
(HDCT group). All HDCT patients also received
autologous bone marrow transplant subsequently.
The HDCT patients were further divided into those
with DLsb evidence for pulmonary capillary injury
(i.e., hemoglobin corrected resting DLsbo75% pre-
dicted—post-HDCT-low DLsb subgroup) and those
without it (i.e., hemoglobin corrected DLsb X75%
predicted—post-HDCT-normal DLsb subgroup).
The HDCT regimens usually included cyclopho-
sphamide, and carmustine.16,17 Some received
cyclophosphamide and cisplatin dosing plus a
maximum tolerated dose of thioTEPA18 or a max-
imum tolerated dose of melphalan, ifosfamide
sodium 2-mercaptoethane sulfonate and carbopla-
tin. All patients received G-CSF primed peripheral
blood progenitor cells or stem cells on day 1, 0
and þ1 and received autologous bone marrow
transplantation (day þ1). Each patient signed an
informed consent and the protocol was approved by
the Institutional Review Board of Duke University
Medical Center.
Single exhalation (intrabreath) test
This technique has been described pre-
viously.10,11,14,15 Briefly, the subject performs a
rapid inhalation from residual volume to total lung
capacity of dilute (0.3% each) CO, C2H2 and CH4.
After a brief breath hold (1–2 s), the subject slowly
exhales at a relatively constant flow rate (0.5–1 l/s)
with the aid of a flow restrictor (5mm critical
orifice) and an on-screen flow indicator. Gas
concentrations are measured continuously during
exhalation by a rapid infrared analyzer system
(model 2200, SensorMedics, Yorba Linda, CA).
Multiple intrabreath DLCO (DLib) values are
calculated using the conventional DLCO equation:
DLib ¼
VA
t2  t1
 ln FAcoðt1Þ
FAcoðt2Þ
 k,
where VA ¼mean alveolar volume over which CO
uptake occurred; t2  t1 ¼ time interval over which
CO uptake occurred; ln (FAcoðt1Þ=FAcoðt2Þ ¼ expo-
nential change in alveolar CO concentration over
the small time interval (t1  t2); and k ¼ constant,
1000 60/(PB47). DL calculations were corrected
for phase III (alveolar phase) slope of CH4 by
expressing CO concentrations relative to CH4.
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Y.-C.T. Huang et al.1228An overall single exhalation DLCO (DLexh) and
single exhalation capillary blood flow (Q cexh) are
calculated by assessing the uptake of CO and C2H2
by the lung during the entire exhalation, respec-
tively, with CH4 as an inert tracer gas using the
following19:
Q cexh ¼ ðVE=aBÞ  flnðFAC2H2oÞ= ln½ðVA þ atVtÞ=
ðVAo þ atVtÞg  ½ð60 1000Þ=ðPB  47Þ,
DLexh ¼ VE  ½lnðFACO=FACOoÞ= lnðVA=VAoÞ
 ½60 1000=ðPB  47Þ,
FAC2H2o ¼ F IC2H2  FECH4=F ICH4,
VAo ¼ ðV I  VDÞ  ðF ICH4=FECH4Þ,
where VE is expiratory flow rate; ln is natural
logarithm; VA is alveolar volume; VAo is alveolar
volume at full inspiration. V I and VD are inspired
volume and dead space volume, respectively; FACO
and FAC2H2 are alveolar concentrations of CO and
C2H2, respectively; FACOo and FAC2H2o are alveolar
concentrations of CO and C2H2, respectively, prior
to beginning of gas absorption; F IC2H2 and F ICH4 are
inspired concentrations of C2H2 and CH4, respec-
tively; FECH4 is expired concentration of CH4; PB is
barometric pressure; aB and at are Bunsen coeffi-
cients for C2H2 in blood and tissue, respectively; Vt
is pulmonary parenchymal tissue volume. Since it
only has a small effect on the calculation of Qcexh,
Vt is assumed to be 700ml. Linear regression with
least-squares analysis was used to calculate the
slope of log fractional C2H2 and CO uptake versus
log exhaled vital capacity. Both DLexh and Q cexh
were corrected for phase 3 (alveolar phase) slope
of CH4 by expressing CO and C2H2 concentrations
relative to CH4.
The value for DLexh has been shown to be
identical to the traditional single breath-hold
DL.10 Qcexh has also been shown to correlate with
other measurements of pulmonary blood flow or
cardiac output.20 The exhaled slope of the inert gas
(CH4) is expressed as a % change over time and is
taken as an index of intrapulmonary gas mixing.Exercise protocol
The exercise level was determined by a target
heart rate equal to (maximum predicted heart
rateresting heart rate)/3þresting heart rate,
where maximum predicted heart rate is 220-
age.10,11 This level was approximately 40% of the
predicted VO2 max.Other clinical tests
Each patient also had standard pulmonary function
test including spirometry, lung volumes and single
breath DL (DLsb) on the day of the single exhalation
intrabreath testing. DLsb was corrected for hemo-
globin using the standard correction.1
Hb-adjusted DLsb
¼ observed DLsbð10:22þ HbÞ=1:7Hb.
Statistical analysis
The data were presented as mean7standard error
(SE). Differences among the three groups were
compared using one-way analysis of variance
(ANOVA) and Tukey’s subtests. The slopes of
DDLexh=DQ cexh were compared using the method
of Kleinbaum et al.21 The statistical analysis was
performed using StatView (version 5.0.1, SAS, Inc.
Cary, NC). A P-value of o0.05 was considered
statistically significant.Results
Patient population
A total of 67 patients were included. Twenty-six
patients were pre-HDCT and all had normal resting
DLsb values (X75% of predicted) (the pre-HDCT
group). Twenty-one patients had received HDCTand
still had a normal DLsb value (the HDCT-normal DLsb
group). These patients had lower lung volumes
compared to the pre-HDCT group although the lung
volumes were still within normal range (490%).
Twenty patients had received HDCT but had a low
resting DLsb (the HDCT-low DLsb group) indicative of
capillary injury. The lung volumes were even lower
but they were still 480% predicted. Key demo-
graphic and clinical data for the three groups are
summarized in Table 1. No patients showed
hematogenous metastasis to the lung based on
the CT findings.
Exercise DL response
The exercise parameters for each of the three
groups are shown in Table 2. All values were similar
with an exception. Study subjects in the HDCT-low
DLsb group had a slightly higher resting heart rate
compared to patients with normal resting DLsb.
The absolute increase in DLexh in both the pre-
HDCT group (4.470.4ml/min/mmHg, P ¼ 0:003)
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Table 1 Demographic and clinical data for the three groups of patients.
Characteristics Pre-HDCT HDCT
Normal DLsb Normal DLsb Low DLsb
n 26 21 20
Age (years) 43 (2) 43 (2) 43 (1)
Height (cm) 164 (1) 164 (1) 164 (1)
Weight (kg) 67.0 (2.7) 65.7 (2.6) 61.3 (2.6)
Days post-HDCT — 212 (59) 237 (54)
FVC (% predicted) 106.8 (2.2) 94.9 (3.0)* 81.7 (3.4)*
FEV1 (% predicted) 99.3 (2.1) 90.9 (2.2)
* 80.9 (3.7)*
TLC (% predicted) 102.5 (2.1) 94.2 (2.1)* 84.2 (3.5)*
DLsb (% predicted) 95.3 (2.5) 87.1 (2.2) 63.1 (1.5)
*
Hemoglobin (g/dl) 11.2 (0.4) 12.7 (0.3) 11.6 (0.3)
HDCT: high-dose chemotherapy. DLsb was hemoglobin-corrected. * Po0.05 versus pre-HDCT. Values shown are mean (SE). The
range of DLsb for the pre-HDCT group was 75.9–115.5% predicted. The range of DLsb for the HDCT-normal DLsb group was
75.0–112.6% predicted. The range of DLsb for the HDCT-low DLsb group was 48.9–72.5% predicted.
Table 2 Exercise parameters for the three groups of patients.
Exercise parameters Pre-HDCT HDCT
Normal DLsb Normal DLsb Low DLsb
Resting HR (beat/min) 100 (3) 106 (4) 110 (3)*
Exercise HR (beat/min) 136 (3) 137 (4) 136 (3)
Max. pred. HR (beat/
min)
178 (2) 177 (2) 177 (1)
Resting O2 saturation (%) 96.4 (0.3) 96.9 (0.2) 96.8 (0.3)
Exercise O2 saturation
(%)
96.5 (0.3) 96.9 (0.2) 96.8 (0.3)
40% VO2 max (ml/min) 802 (9) 800 (9) 797 (8)
Power output (W) 52 (1) 52 (2) 51 (2)
HR: heart rate. HDCT: high-dose chemotherapy. * Po0.05 versus pre-HDCT. Values shown are mean (SE).
Regional DLCO and lung injury 1229and the HDCT-normal DLsb group (4.370.6ml/min/
mmHg, P ¼ 0:002) was similar to the predicted
exercise DLexh increase seen in our previous study
of normal female subjects10 (Fig. 1). In contrast,
the absolute increase in DLexh in the HDCT-low DLsb
group (2.470.4ml/min/mmHg) was significantly
smaller than the other two groups (P ¼ 0:003 and
0:002, respectively) (Fig. 1). Fig. 2 showed the DLib-
lung volume profile during the single exhalation at
rest and during exercise for all three groups. Note
that, like our previous study,11 the pre-HDCT group
had relatively uniform exercise increases in DLib
over all lung volumes. In contrast, the HDCT-low
DLsb group had markedly diminished exercise
increases in DLib at a given exhaled VC (compared
to the pre-HDCT group as indicated by *), especially
when measured in the slower emptying units. More
importantly, the HDCT-normal DLsb group also had a
significantly smaller exercise increase in DLib from
the very late emptying lung units.Changes in Qcexh during exercise
Resting Qcexh was similar in all three groups
(Fig. 3A), although heart rate was higher and
stroke volume (Qcexh/heart rate) was lower in the
HDCT-low DLsb group (Fig. 3B and C). With exercise,
Qcexh increased by approximately 100% in all
three groups, a change similar to the 117% increase
predicted from our previous study in normal
female subjects using this protocol.10 The slope of
the changes in DLexh/Qcexh with exercise was
significantly lower in the HDCT-low DLsb group
(0.85) versus the pre-HDCT (1.48) and the HDCT-
normal DLsb group (1.33) (Fig. 4).Changes in the CH4 slope during exercise
The CH4 slopes during rest and exercise in the pre-
HDCT patients were similar to those predicted from
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Y.-C.T. Huang et al.1230our previous study in normal female subjects
(0.007%/s at rest and 0.008%/s during exercise).11
In contrast, this slope was significantly increased at
rest in both HDCT groups and further increased
significantly in the HDCT-low DLsb group with
exercise (Fig. 5).0.0
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Figure 2 The volume-dependent profile of intrabreath
DL during a single exhalation in patients with normal
resting DLsb before receiving high-dose chemotherapy
(pre-HDCT), patients who had received chemotherapy
but with normal resting DLsb (HDCT-normal DLsb) and
patients who had received chemotherapy but with low
resting DLsb (HDCT-low DLsb). * Indicates that the increase
in intrabreath DL at the given lung volume are signifi-
cantly smaller than that at the corresponding lung
volume in the pre-HDCT patients (Po0:05).Discussion
At rest, the pulmonary capillary bed is neither
maximally recruited nor dilated.22 Exercise in-
creases pulmonary capillary blood flow and conse-
quently pulmonary capillary blood volume. It thus
follows that early or subtle pulmonary capillary
abnormalities might be detected more readily with
pulmonary capillary function assessments done
during exercise. Moreover, because these capillary
changes may not be uniform throughout the lung,
pulmonary capillary function assessments in differ-
ent lung regions might provide further diagnostic
sensitivity. Our DLexh technique to measure ex-
ercise CO uptake (along with Qcexh and the CH4
slope), especially with the DLib analysis, may offer
the potential to detect these subtle changes.
In this study, we have shown using the DLib
technique that CO uptake (DL) abnormalities can
be demonstrated in HDCT patients at risk for
pulmonary capillary injury, even in those with
normal pulmonary function testing (including the
single breath measurements of DL) at rest. Indeed,we found that the most significant reductions in the
CO uptake response to exercise in the HDCT
patients with a low resting DLsb were in the later
emptying regions of the lung. Moreover, in the
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Regional DLCO and lung injury 1231subgroup of HDCT patients with a normal resting
DLsb, the only evidence for CO uptake abnormal-
ities was the reduced exercise DL response in the
latest emptying regions of the lung. These results
thus suggest that the DLib technique might be a
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Y.-C.T. Huang et al.1232very sensitive tool for detecting subtle pulmonary
capillary injury.
Our technique also allowed for a calculation of
Qcexh at exercise and this doubled in all three of our
subgroups with this exercise protocol. Qcexh mea-
surements further allowed us to calculate the
relative change in DL to Qc with exercise
(DDL=DQ c slopes). This slope in the pre-HDCT
patient and the HDCT-normal DLsb groups (1.48
and 1.33, respectively) was similar to that reported
by us in normal female subjects, but reduced in the
HDCT-low DLsb groups (0.85).
The DL response to exercise has been shown to be
reduced by others in different disease populations.
Chu and Cotes found in patients with occupational
lung diseases that DLsb increased from 20.4 to
22ml/min/mmHg (or 8%) during exercise at a heart
rate of 100 beats/min.3 Hughes et al. found in five
patients with severe fibrosing alveolitis that re-
breathing DL increased from 8.0 at rest to 9.6ml/
min/mmHg (or 20%) during exercise at 60W. These
workers further showed that there was also a
reduced DDL=DQ c slope during exercise of 0.28.
12
More recently, Phansalkar et al. reported in 25
patients with sarcoidosis and moderate restrictive
defect that rebreathing DL increased from 6.5 at
rest to 10.2ml/min/mmHg (or 57%) during exercise
at 80% peak workload giving an average DDL=DQ c
slope of 0.87 (versus 1.52 in the their normal
controls).13 The patients included in these studies
had relatively severe lung diseases as evidenced by
reduction in lung volumes and DL to approximately
50–60% of normal consistent with significant lung
parenchymal abnormalities and structural distor-
tion. To our knowledge, our data in the post-HDCT
normal DLsb subgoup are the first reported on the
DL response to exercise in patients at risk for
pulmonary capillary injury but with normal DLsb
values.
Interestingly, we also found a significant steepen-
ing of the slope of the inert gas CH4 during both at
rest and exercise in the HDCT groups, suggesting
intrapulmonary gas mixing was impaired in these
patients, possibly due to airway injury caused by
HDCT, bone marrow transplantation or breath
cancer metastasis. This impaired mixing may
contribute to different CO sampling patterns during
exhalation in the exercise versus resting lungs (i.e.,
the incremental volume sampling might reflect
different regions during rest and exercise). It is
thus possible that some of the DL exercise
responses we observed in the HDCT patients might
reflect different regional sampling during the rest
and exercise intrabreath analysis.23,24
Pathologically, lung toxicity caused by HDCT is
characterized by alveolar septal thickening withfibrosis, atypical alveolar type II cells and pulmon-
ary endothelial cell injury.25 Two agents in the
protocols, cyclophosphamide and carmustine, have
been implicated in the pathogenesis of HDCT-
induced lung toxicity and are thought to act
synergistically to deplete reduced glutathione and
impair antioxidant defenses.25 The physiological
derangement shown in our study (i.e., decreased
DLib response with exercise at low lung volumes)
might reflect an earlier stage of these pathological
findings. Furthermore, since our patients did not
desaturate during exercise, exercise response of
DLib may be a more sensitive measurement than O2
saturation for HDCT-induced lung toxicity. The
clinical value of these results awaits future studies
in which exercise capacity, gas exchange during
exercise and clinical outcome of the patients with
or without specific treatment strategies can be
assessed.
In summary, our study showed that HDCT patients
at risk for pulmonary injury had abnormal regional
CO uptake properties under exercise conditions
even when resting DLsb values were normal. This
decreased CO uptake occurred primarily at lower
lung volumes and was associated with increased
ventilation time constant inhomogeneity. Assess-
ment of the volume-dependent DLib profile during
exercise may help understand the mechanisms of
functional abnormalities in pulmonary capillaries in
lung diseases.
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